2022
DOI: 10.1016/s0140-6736(22)01245-4
|View full text |Cite
|
Sign up to set email alerts
|

COVID-19 vaccination for children aged 5–11 years

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
16
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 16 publications
(16 citation statements)
references
References 19 publications
(29 reference statements)
0
16
0
Order By: Relevance
“…26 Covid-19 vaccination may protect children under 5 at high risk of severe disease. 27 But the case for mass vaccination of healthy under 5s seems less compelling, 15 particularly in developed countries where risk of mortality from covid-19 in this age group is so low. 28 However, the balance of benefits and risks may change as new variants emerge.…”
Section: Opportunity Costsmentioning
confidence: 99%
See 4 more Smart Citations
“…26 Covid-19 vaccination may protect children under 5 at high risk of severe disease. 27 But the case for mass vaccination of healthy under 5s seems less compelling, 15 particularly in developed countries where risk of mortality from covid-19 in this age group is so low. 28 However, the balance of benefits and risks may change as new variants emerge.…”
Section: Opportunity Costsmentioning
confidence: 99%
“…Covid-19 vaccination could reduce incidence of severe disease among under 5s considered at highest risk15 and may protect them against the rarer multisystem inflammatory syndrome, as observed in children aged over 12 years 18. This complication has also been reported after covid-19 vaccination in older children, but at lower rates than occur following natural infection 19.…”
mentioning
confidence: 98%
See 3 more Smart Citations